|
|
Volumn 52, Issue 5, 2004, Pages 843-844
|
|
Donepezil's effects remain uncertain.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
INDAN DERIVATIVE;
NOOTROPIC AGENT;
PIPERIDINE DERIVATIVE;
PLACEBO;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
FOLLOW UP;
HUMAN;
INSTITUTIONALIZATION;
NOTE;
NURSING HOME;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIAL;
THEORETICAL MODEL;
TIME;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
DOUBLE-BLIND METHOD;
FOLLOW-UP STUDIES;
HUMANS;
INDANS;
INSTITUTIONALIZATION;
MODELS, THEORETICAL;
NOOTROPIC AGENTS;
NURSING HOMES;
PATIENT COMPLIANCE;
PIPERIDINES;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
MLCS;
MLOWN;
|
|
EID: 2542499754
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1532-5415.2004.52230_2.x Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
